9 Meters Biopharma Other Current Assets

The latest other current assets for NMTR is $1.6M as of March 2023. That compares with $1.8M in the prior-year period — down 14.7% year over year. Investors often review this figure alongside 9 Meters Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTR's other current assets moved from $1.8M to $1.6M — a 14.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 9 Meters Biopharma's operating scale or balance-sheet position.

A other current assets figure of $1.6M for NMTR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMTR's other current assets ($1.6M), review year-over-year change from $1.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 9 Meters Biopharma's other current assets against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.